ABEL MENDEZ: Open Payments
NPI 1366896888 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 25 payments from 7 companies in 2025. Trend: 2023 $259 · 2024 $578 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 12 | $237 |
| Aimmune Therapeutics, Inc. | 4 | $94 |
| Gilead Sciences, Inc. | 3 | $78 |
| Shionogi Inc | 2 | $52 |
| ViiV Healthcare Company | 2 | $48 |
| Grifols USA, LLC | 1 | $23 |
| Octapharma USA, Inc. | 1 | $20 |
Products named: NUZYRA, VOWST, Fetroja, CABENUVA, Gamunex-C, PANZYGA.
Industry payments across TX — which companies pay providers there.
